AILEEN DEAMER: Open Payments
NPI 1164418265 · NEWINGTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$236 in 11 payments from 8 companies in 2025. Trend: 2023 $245 · 2024 $365 · 2025 $236
Food & beverage: $236
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $67 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $62 |
| GENZYME CORPORATION | 1 | $27 |
| LEO Pharma Inc. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| ABBVIE INC. | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
| Organon LLC | 1 | $7 |
Products named: TREMFYA, ILUMYA, DUPIXENT, Winlevi, ANZUPGO, Sotyktu, RINVOQ, Rhapsido.
Industry payments across CT — which companies pay providers there.
